News
Dec. 11, 2017 (GLOBE NEWSWIRE) -- TeneoBio, Inc. yesterday presented preclinical data on its lead therapeutic candidate, TNB-383B ... and high-throughput vector assembly technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback